iNtRON Biotechnology Inc (048530) — Cash Flow Quality Index
iNtRON Biotechnology Inc (048530) has a Cash Flow Quality Index of -4.73x as of June 2024. Operating cash flow of ₩-2.74 Billion is below net income of ₩579.25 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore iNtRON Biotechnology Inc (048530) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
iNtRON Biotechnology Inc Cash Flow Quality Index (2015–2022)
Historical Cash Flow Quality Index for iNtRON Biotechnology Inc across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of iNtRON Biotechnology Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for iNtRON Biotechnology Inc (2015–2022)
Year-by-year earnings quality comparison for iNtRON Biotechnology Inc. For live market cap and the full company financial profile, see market value of iNtRON Biotechnology Inc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.05x | ₩5.98 Billion | ₩5.71 Billion | ▼ -38.2% |
| 2021 | 1.69x | ₩16.47 Billion | ₩9.73 Billion | ▲ +255.0% |
| 2020 | 0.48x | ₩7.13 Billion | ₩14.95 Billion | ▼ -1.1% |
| 2018 | 0.48x | ₩4.20 Billion | ₩8.71 Billion | ▼ -55.8% |
| 2015 | 1.09x | ₩1.70 Billion | ₩1.56 Billion | — |